glp 1 oral drug Structure Therapeutics GLP-1 Obesity Achieves 'Injectable-Like Efficacy' in Phase 2 Test GLP-1 Oral Solution – Affordable
Description
This approval is an important milestone for people living with obesity and cardiovascular disease, as the SELECT data demonstrated that Wegovy has the potential to prolong lives by addressing some of the leading causes of preventable deaths by reducing the risks of cardiovascular events.
[DOI] [PMC free article] [PubMed] [Google Scholar] 7.Willard F
Watch for signs of dehydration: Dark urine, dry mouth, headaches, and dizziness are all signals that you need more fluids
Its associated with modest weight loss
In the pancreas, GLP-1RAs are well known to promote insulin secretion
